A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors
Anyue Yin,Dirk Jan A.R. Moes,Johan G.C. van Hasselt,Jesse J. Swen,Henk-Jan Guchelaar +4 more
- Vol. 8, Iss: 10, pp 720-737
TLDR
The opportunities of a model‐based approach as discussed in this review can be of great benefit for future optimizing and personalizing anticancer treatment.Abstract:
Increasing knowledge of intertumor heterogeneity, intratumor heterogeneity, and cancer evolution has improved the understanding of anticancer treatment resistance. A better characterization of cancer evolution and subsequent use of this knowledge for personalized treatment would increase the chance to overcome cancer treatment resistance. Model-based approaches may help achieve this goal. In this review, we comprehensively summarized mathematical models of tumor dynamics for solid tumors and of drug resistance evolution. Models displayed by ordinary differential equations, algebraic equations, and partial differential equations for characterizing tumor burden dynamics are introduced and discussed. As for tumor resistance evolution, stochastic and deterministic models are introduced and discussed. The results may facilitate a novel model-based analysis on anticancer treatment response and the occurrence of resistance, which incorporates both tumor dynamics and resistance evolution. The opportunities of a model-based approach as discussed in this review can be of great benefit for future optimizing and personalizing anticancer treatment.read more
Citations
More filters
Book ChapterDOI
The Mathematical Model
TL;DR: The death rate per tumor cell due to immunological response is proportional to the total number of antigen-producing (tumor) cells; thus, the total death rate is quadratic.
Journal ArticleDOI
Cancer modeling: From mechanistic to data-driven approaches, and from fundamental insights to clinical applications
TL;DR: A non-exhaustive overview of models according to their intrinsic features of in silico cancer models is provided, using the hallmarks of cancer as a guidance.
Journal ArticleDOI
Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth
Pierluigi Colli,Hector Gomez,Guillermo Lorenzo,Guillermo Lorenzo,Gabriela Marinoschi,Alessandro Reali,Elisabetta Rocca +6 more
TL;DR: The results suggest that only cytotoxic chemotherapy is required to optimize therapeutic performance and it is shown that the optimal control framework can produce superior solutions to combined therapy with docetaxel and bevacizumab.
Journal ArticleDOI
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities.
TL;DR: This review is to comprehensively summarize the history of TGD, and present case examples of the recent advance ofTGD modeling (mixture model and joint model), as well as the TGD impact on regulatory decisions, thus illustrating challenges and opportunities.
Journal ArticleDOI
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.
Stefania Crucitta,Federico Cucchiara,Ron H.J. Mathijssen,Joaquin Mateo,Agnes Jager,Arjen Joosse,Antonio Passaro,Ilaria Attili,Iacopo Petrini,Ron H.N. van Schaik,Romano Danesi,Marzia Del Re +11 more
TL;DR: In this paper , the authors focused on tumour heterogeneity and its relation to resistance to targeted-therapy, based on treatment selective pressure across different tumour types, including lung, colorectal, prostate, breast cancer and melanoma.
References
More filters
Journal ArticleDOI
Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm.
Emmanuel Mandonnet,Johan Pallud,Olivier Clatz,Luc Taillandier,Ender Konukoglu,Hugues Duffau,Laurent Capelle +6 more
TL;DR: In this paper, WHO grade II glioma will serve as a paradigmatic example to illustrate that computational models allow characterizing tumor dynamics from serial MRIs and the role of these dynamics for both therapeutic management and biological research will be discussed.
Journal ArticleDOI
Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
TL;DR: A mathematical model of personalized cancer therapy incorporating genetic evolutionary dynamics and single-cell heterogeneity is developed, and simulated clinical outcomes are examined, demonstrating that augmented (and sometimes counterintuitive) nonstandard personalized medicine strategies may lead to superior patient outcomes compared with the current personalized medicine approach.
Journal ArticleDOI
Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates.
TL;DR: A modeling approach was used to connect cellular mechanisms underlying cancer drug resistance to population-level patient survival and developed a set of stochastic differential equations to describe the dynamics of heterogeneous cell populations while taking into account micro-environment adaptations that predicted progression-free survival in cancer patients with metastatic melanoma.
Journal ArticleDOI
Mathematical modelling of prostate cancer growth and its application to hormone therapy
TL;DR: In this paper, the authors presented an extended model of stochastic differential equations and examined how well the model is able to capture the characteristics of authentic serum prostate-specific antigen (PSA) data.
Journal ArticleDOI
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation☆
TL;DR: Gathering knowledge from cancer and evolutionary biology with physiologically based mathematical models of cell population dynamics should provide oncologists with a rationale to design optimised therapeutic strategies to circumvent drug resistance, that still remains a major pitfall of cancer therapeutics.